Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Global Market Value Of The Tumor Embolization Devices Industry In 2025?
The market valuation for tumor embolization devices has experienced substantial expansion lately, projecting an upward trajectory from $1493.6 billion in 2024 to $1587.48 billion in the subsequent year, reflecting a consistent compound annual growth rate of 6.3%; this robust expansion observed during the past period is fundamentally linked to the increasing adoption of less invasive medical operations, ongoing progress in medical technology, a higher prevalence of cancer diagnoses, and demographic shifts toward an older populace.
The overall valuation of the tumor embolization devices sector is projected to experience a robust expansion over the coming years, reaching an estimated $2254.67 billion by 2029, reflecting a steady compound annual growth rate (CAGR) of 9.2% throughout the projection span. This upward trajectory is being fueled by advancements such as personalized medical approaches, the adoption of combination treatments, sophisticated image-guided embolization techniques, and the increasing use of telemedicine and remote consultative services. Key developments anticipated in the coming period encompass novel developments concerning embolic agents, the expanding role of transarterial chemoembolization (TACE), the utilization of embolization for alleviating patient discomfort (palliative care), and continuous refinement in image-guided procedural methods.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3352&type=smp
Which Major Market Drivers Are Shaping The Future Of The Tumor Embolization Devices Market?
A global escalation in cancer diagnoses is projected to fuel the expansion of the tumor embolization devices market throughout the predicted timeframe. To illustrate this trend, Macmillan Cancer Support, the foremost healthcare charity in the United Kingdom, provided figures in October 2022 predicting that the cancer patient population would reach 3.5 million by the year 2025, increase further to 4 million by 2030, and ultimately climb to 5.3 million by 2040; consequently, the increasing worldwide rate of cancer occurrences is expected to drive up the need for tumor embolization solutions in the years ahead.
What Are The Major Segment Types Covered In The Tumor Embolization Devices Market?
The tumor embolization devicesmarket covered in this report is segmented –
1) By Type: Radioembolic Agents, Non-radioactive Embolic Agents
2) By Application: Cancer Tumors, Noncancerous Tumors
3) By End User: Hospitals, Cancer Treatment Centers, Intensive Care Units, Surgical Centers
Subsegments:
1) By Radioembolic Agents: Yttrium-90 (Y-90) Microspheres, Holmium-166 Microspheres
2) By Non-radioactive Embolic Agents: Drug-Eluting Beads (DEBs), Microspheres (Polyvinyl Alcohol – PVA Particles), Gelatin Sponges, Liquid Embolic Agents (Onyx, Glue-Based Agents)
How Are Emerging Market Trends Shaping The Tumor Embolization Devices Industry Landscape?
Key enterprises within the sphere of tumor embolization apparatuses are actively developing novel offerings, such as angiography instrumentation, with the goal of boosting the precision and efficacy associated with treatments focused on tumors. These angiography apparatuses serve as dedicated imaging technologies employed for mapping out vascular pathways and evaluating circulatory dynamics within the patient’s body. As an illustration, in the month of June in 2022, Siemens Healthineers, a corporation headquartered in Germany specializing in healthcare solutions, introduced the Artis Icono Ceiling; this particular angiography setup, which is mounted to the ceiling, was engineered to augment exactness during tumor embolization procedures and other minimally invasive interventions. What distinguishes the Artis Icono Ceiling is its capacity for swift acquisition of three-dimensional (3D) information, enabling image capture from the patient’s head region in a mere 2.5 seconds and from lateral angles in 4 seconds, a capability that substantially lessens image distortions caused by movement and concurrently lowers the requisite volume of contrast agents. Furthermore, the Artis Icono Ceiling has been conceived with adaptability in mind, positioning it as a suitable tool for deployment across several medical disciplines, notably interventional radiology and cardiology.
Which Key Players Are Driving Competition In The Tumor Embolization Devices Market?
Major companies operating in the tumor embolization devices market include Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Sirtex Medical Limited, Merit Medical Systems Inc., Cook Medical LLC, AngioDynamics Inc., Siemens Healthineers AG, Johnson & Johnson, Penumbra Inc., Teleflex Incorporated, Meril Life Sciences Pvt. Ltd., Kaneka Corporation, Imagion Biosystems Ltd., Guerbet, BTI Biotechnology Institute S.L., BTG International, Avinger Inc., Shape Memory Medical Inc., Delcath Systems Inc., Endoshape Inc., InSitu Technologies Inc., Monteris Medical Corporation, NeuWave Medical Inc., Neoprobe Corporation, OncoSec Medical Incorporated, Helomics Corporation, Hologic, Surefire Medical Inc., Varian Medical Systems Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report
What Regional Growth Trends Are Shaping The Tumor Embolization Devices Market Outlook?
North America was the largest region in the tumor embolization devices market in 2024. Asia-Pacific was the second largest region in the tumor embolization devices market. The regions covered in the tumor embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Tumor Embolization Devices Market Report:
https://www.thebusinessresearchcompany.com/customise?id=3352&type=smp
Browse Through More Reports Similar to the Global Tumor Embolization Devices Market 2025, By The Business Research Company
Cardiac Assist Devices And Equipment Global Market Report 2025
Pain Management Devices And Therapies Global Market Report 2025
Implantable Drug Delivery Devices Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model